TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05117463

Intervention type: OTHER
Intervention: Optic Flow Stimulation
Description: The optic flow will be displayed at different speeds. The subject will need to look at the center of the optic flow.

Intervention type: OTHER
Intervention: Optic Flow Stimulation
Description: The optic flow will be displayed at different speeds. The subject will need to look at the center of the optic flow.

Intervention type: OTHER
Intervention: Optic Flow Stimulation
Description: The optic flow will be displayed at different speeds. The subject will need to look at the center of the optic flow.

Intervention type: OTHER
Intervention: Auditory Reaction Time
Description: Two different pitches of tones will be played. The participants will need to press a button on the right or left hand based on the pitch of the tone.

Intervention type: OTHER
Intervention: Auditory Reaction Time
Description: Two different pitches of tones will be played. The participants will need to press a button on the right or left hand based on the pitch of the tone.

Intervention type: OTHER
Intervention: Auditory Reaction Time
Description: Two different pitches of tones will be played. The participants will need to press a button on the right or left hand based on the pitch of the tone.
Study: NCT05569265

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intraoperative hemodynamic management
Description: Goal directed Hemodynamic therapy
Study: NCT05121649

Intervention type: OTHER
Intervention: Video streaming
Description: Video streaming as a supplement to telephone during emergency calls for dispatchers at EMCCs
Study: NCT04991246

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individual electronic sensor port
Description: Individual electronic sensor recording contacts but not their location (in the form of a bracelet, a key ring or a badge) Contact data collection points (5 maximum, located at compulsory passage points for participants). When a sensor is close to one of these terminals, it discharges its contacts in seconds.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Atmospheric measurements of CO2
Description: Atmospheric measurements of CO2 in the relevant closed places of the faculty (lectures / practical work / BU / refectory): battery operated sensors. When a sensor is installed in a place, the ventilation conditions (number of open windows, etc.) as well as the number of people present will be noted.
Study: NCT06389071

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fractional 2940 nm Laser
Description: Fractional 2940 nm Laser

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fractional 2940 nm Laser
Description: Fractional 2940 nm Laser
Study: NCT05256836

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tablet computer-based cognitive training program
Description: The subject of the study executes a program mounted on a tablet personal computer (PC) (Samsung Galaxy Tab S6 Lite) and performs a cognitive training task by touching the screen with the index finger.~It consists of 10 tasks related to the activity of daily living: 1) taking medicine, 2) making a phone call, 3) taking a shower, 4) doing laundry, 5) finding directions, 6) riding the bus, 7) buying goods, 8) Money management, 9) ingredient sorting, 10) meal preparation.~It is involved in cognitive functions in various domains such as attention, working memory, processing speed, problem solving, visuospatial ability, verbal and visuospatial memory.~There are three levels of difficulty for each task, high, medium, and low, and the difficulty becomes more difficult as session 1 to 36 progresses.~One cognitive training session lasts about 30 minutes.
Study: NCT04285671

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Necitumumab
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osimertinib
Description: Given PO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: Given IV
Study: NCT05696691

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine Hydrochloride
Description: 100mg IM ketamine to be administered in conjunction with CRP. The ketamine injection will be administered first. Participants will be observed and have vital signs monitored for the first 45 minutes after administering medication in the ED, observing for immediate reactions. Afterwards, participants will continue to be monitored for potential late-term side effects on the inpatient unit. Ketamine will be given only after initial standard of care (SOC) treatment and screening studies have been initiated.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Crisis Response Plan
Description: Crisis Response Plan is a brief, empirically-validated, Cognitive-Behavioral Therapy-based one-time therapy, and its administration typically takes 30-60 minutes. It begins with a narrative assessment (allowing patients to tell their story) and concludes with collaboratively constructed plan that outlines strategies for the patient's self-management of future acute suicidal crises. Patients who engage in CRP are given an index card to keep with them that summarizes the emotional management strategies that they collaboratively generate with the CRP provider.
Study: NCT06159946

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Access-H2O faucet
Description: The assigned invention was developed to test the feasibility of the prototype of the Access-H2O faucet by assessing whether subjects can activate the faucet to control water outputs via the motion sensor, eye gaze, and a speech speaker. To activate the faucet via the motion sensor, each subject was asked to place his or her hand near the motion sensor. To activate the faucet via the eye gaze, each subject was asked to look directly at the eye gaze sensor. To activate the faucet via the speech speaker, each subject was asked to speak to the speaker. Each subject performed the same function three times. The water from the faucet was used for drinking, rinsing, and grooming.
Study: NCT05852106

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surgical Simulation with 3D Heart Model and Parental Education with Congenital Heart Disease Parent Education Booklet and tailored 3D Heart Modeling
Description: The first step in the modeling process is masking. For this study, the average minimum value for masking ventricles and large vessels was set between 80 and 200 HU (Brüning et al., 2022). Threshold values of min 216 HU - max 1502 HU are used. At these HU values, the blood in the heart and great vessels is masked and the outline of the heart is revealed. Lowering the minimum HU value is necessary to make the heart walls more visible. However, this results in masking unwanted soft tissues other than the heart, such as muscle and fat. The masked unnecessary surrounding tissues are removed first with the cropping mask and then manually by marking along the contours of the heart and great vessels. Thus, a model containing only the heart and the desired large vessels will be created and cleaned from the surrounding tissues. With this mask, 3D reconstruction will be performed, and the model will be ready for printing.
Study: NCT06286878

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will be randomized to use dapagliflozin or placebo in a double-blind way

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Patients will be randomized to use dapagliflozin or placebo in a double-blind way
Study: NCT06561048

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Soquelitinib
Description: Soquelitinib 200 mg tablets will be taken by mouth two times a day

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Belinostat
Description: Belinostat (1000 mg/m2) will be administered by intravenous infusion once daily on Days 1 through 5 of each 21-day cycle

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pralatrexate
Description: Pralatrexate (30 mg/m2) will be administered intravenously over 3 to 5 minutes once weekly for 6 weeks in each 7-week cycle
Study: NCT05537259

Intervention type: OTHER
Intervention: Observation Group
Description: No intervention; this is an observational study.
Study: NCT06455670

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sanhan Huayin recipe, Qingre Huatan recipe or Zaoshi Huatan recipe
Description: On the basis of conventional treatment of western medicine,the experimental group will be given Sanhan Huayin granule , Qingre Huatan granule or Zaoshi Huatan granule based on CM syndrome differentiation.Take 1 dose daily for 10 days.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sanhan Huayin recipe placebo, Qingre Huatan recipe placebo or Zaoshi Huatan recipe placebo
Description: On the basis of conventional treatment of western medicine, in the experimental group 5% of the placebo drug, color, smell, taste, appearance, weight, similar to the experimental drug, drug packaging and test group. One dose was given daily for 10 days.
Study: NCT05607056

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sinquanon
Description: This probiotic food supplement includes fourteen probiotic bacterial strains of Lactobacillus Spp, Bifidobacterium Spp., Bacillus coagulans, Saccharomyces boulardii, three prebiotics and Vitamin-B complex - B1, B2, B3, B6, B7, B9 in an enterosolvent cellulose capsule. The product includes supplementary substances: maltodextrin and magnesium stearate.~2 capsules once a day during the antibiotic dosing. 1 capsule a day for 14 days following completion of antibiotic dosing.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo product will have the same appearance as the active product and the same composition but without the live bacteria, prebiotics, and vitamin-B complex. 2 capsules once a day during the antibiotic dosing. 1 capsule a day for 14 days following completion of antibiotic dosing.
Study: NCT06470334

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: Ultrasound-guided PENG block - 20ml 0,2% ropivacaine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine+Dexamethasone
Description: Ultrasound-guided PENG block - 10ml 0,2% ropivacaine + 4mg Dexamethasone
Study: NCT06439186

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocain
Description: Local anesthesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocain
Description: Local anesthesia
Study: NCT05206123

Intervention type: OTHER
Intervention: Interview
Description: Patients will be interviewed with a semi-structured qualitative interview in order to know how they lived their first sexual experiences and their sex lives during their adolescence
Study: NCT05417685

Intervention type: DEVICE
Intervention: Acute and post-acute
Description: These programs will cover patients suffering from acute or post-acute musculoskeletal conditions including, but not limited to, shoulder pain (tendinitis/impingement/bursitis), neck pain, low back pain, knee or hip pain/osteoarthritis, which significantly impact their quality of life, to the extent they seek specialised care in direct relation to these disorders.
Study: NCT04775160

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SmartSafe
Description: The SmartSafe Ecological Momentary Intervention is contained in the MEmind smartphone application and consists of a Safety plan, an Enhanced contact via app (app-EC) intervention, and a mental toolbox. The Safety plan is a set of personalized coping strategies that the patient can use in a suicidal crisis. Our safety plan was adapted to a digital environment, including the possibility to activate pre-recorded messages, lead to websites with health resources, or put the patient in contact with the emergency services. The Enhanced contact via app (app-EC) intervention is inspired by the SIAM project and consists in messages that will be sent via the MEmind app inquiring patients about their mental well-being and informing them of the means to request preferential or urgent care. The mental toolbox contains videos relaxation techniques videos and behavioral activation and mentalization exercises.
Study: NCT05192239

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: THC 5
Description: 5 milligrams of THC in gummy form

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Commercially available non-THC fruit snack
Study: NCT04975711

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP2105
Description: Test drug

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP2105
Description: Test drug

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RLD2104
Description: Reference drug

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RLD2104
Description: Reference drug
Study: NCT05204992

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ultrasound guided hydrodissection
Description: Injection of steroids, saline and bupivicaine ultrasound guided
Study: NCT04740450

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Description: skin colored Kinesio-Tex Gold tape, 50 mm _ 5 m (Kinesio Holding Corp, Albuquerque, NM) tapped in technique described by Gozluklu et al in 2020

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Wound Tape
Description: skin colored wound tape tapped in technique described by Gozluklu et al in 2020
Study: NCT04856033

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TM
Description: Transcendental Meditation instruction, 12-sessions over 3-4 months with monthly follow-up
Study: NCT05420610

Intervention type: OTHER
Intervention: Control group: Patients being admitted when The advancement of transpulmonary thermodilution(TPTD) device was unavailable.
Description: The control group included patients being admitted when TPTD device was unavailable; and relatively stable patients without the need for TPTD. The adequacy of fluid resuscitation in the control group was monitored by traditional monitoring parameters including vital signs and hourly urine output.

Intervention type: OTHER
Intervention: Study group: TPTD device was implemented for monitoring.
Description: TPTD device was implemented for monitoring; the inclusion criteria included patients suffering from 2nd degree burn greater than 40% TBSA; a combined 2nd to 3rd degree burn greater than 30% TBSA; or patients with inhalation injury despite the burned surface area.
Study: NCT05417685

Intervention type: DEVICE
Intervention: Chronic
Description: These programs will cover patients suffering from chronic musculoskeletal conditions including, but not limited to, shoulder pain (tendinitis/impingement/bursitis), neck pain, low back pain, knee or hip pain/osteoarthritis, which significantly impact their quality of life, to the extent they seek specialised care in direct relation to these disorders.

Intervention type: DEVICE
Intervention: Post-surgical
Description: These programs will cover patients submitted to surgery for a given musculoskeletal condition, including, but not limited to, shoulder tendon repair, shoulder replacement, spinal surgery, hip or knee replacement, meniscal repair, knee ligament reconstruction, undergoing physical rehabilitation programs after surgery.
Study: NCT06573931

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lumbar Erector Spinae Plane Block
Description: Patients will receive lumbar erector spinae plane block at the end of surgery.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fascia Iliaca Block
Description: Patients will receive fascia iliaca block at the end of surgery.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lumbar Plexus Block
Description: Patients will receive lumbar plexus block at the end of surgery.
Study: NCT06535516

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Trauma-Focused Cognitive Behavioral Therapy (TF-CBT)
Description: TF-CBT is a well-established trauma treatment for children ages 3-17 years that demonstrates improved outcomes relative to other active treatments. Originally developed for treatment of childhood sexual abuse, evidence from numerous randomized clinical trials (RCT) demonstrates that TF-CBT is one of the most effective treatments for children with PTSD and/or depression resulting from many forms of child abuse and neglect as well as other traumatic experiences.TF-CBT is rated by California Evidence-Based Clearinghouse for Child Welfare as highly relevant for child welfare and well-supported in improving children's outcomes, including reduced PTSD symptoms, behavior problems, depression, and shame, and improving parental support related to their children's experiences.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive Behavioral Therapy (TF-CBT)
Description: TF-CBT is a well-established trauma treatment for children ages 3-17 years that demonstrates improved outcomes relative to other active treatments. Originally developed for treatment of childhood sexual abuse, evidence from numerous randomized clinical trials (RCT) demonstrates that TF-CBT is one of the most effective treatments for children with PTSD and/or depression resulting from many forms of child abuse and neglect as well as other traumatic experiences.TF-CBT is rated by California Evidence-Based Clearinghouse for Child Welfare as highly relevant for child welfare and well-supported in improving children's outcomes, including reduced PTSD symptoms, behavior problems, depression, and shame, and improving parental support related to their children's experiences.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) augmented with Racial Socialization (RS)
Description: The study will compare standard TF-CBT with TF-CBT augmented with Racial Socialization enhancements. TF-CBT+RS includes enhancements to address racial stress and trauma and provide coping strategies to support positive racial socialization.
Study: NCT06472297

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The continuous glucose monitoring system
Description: CGM device worn on back of the arm and glucose readings are shown on the participant's smartphone as a continuous data stream.
Study: NCT06067841

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986460
Description: Specified dose on specified days.
Study: NCT06336629

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Winlevi (clascoterone) 1% & Duac gel
Description: Participants will use Winlevi (clascoterone) 1% and Duac gel as per label
Study: NCT06499272

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional occupational therapy sessions + NeuronUP
Description: Occupational therapy sessions are based on cognitive stimulation, manipulative skill training and psychomotor skills. In addition, 2 sessions per week are conducted with two Nintendo Switch games.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional occupational therapy sessions
Description: Occupational therapy sessions are based on cognitive stimulation, manipulative dexterity training and psychomotor skills.
Study: NCT04812886

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Epidemiological study
Description: Questionnaires (quality of life, gout, life habit, comorbidities) anthropometrics and health measures DNA analysis RNA analysis Metabolomic analysis
Study: NCT04856033

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: PCT
Description: Present Centered Therapy, 12-sessions over 3-4 months with monthly follow-up
Study: NCT06367751

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ctDNA measurement
Description: Blood samples are collected as part of standard of care and ctDNA measurements will be performed on these samples.
Study: NCT06178276

Intervention type: DIAGNOSTIC_TEST
Intervention: behavior
Description: behavioral measurements will be performed during the oral comprehension testing

Intervention type: DIAGNOSTIC_TEST
Intervention: behavior
Description: behavioral measurements will be performed during the oral comprehension testing

Intervention type: DIAGNOSTIC_TEST
Intervention: physiology
Description: physiologic (autonomic) measurements will be performed during the oral comprehension testing

Intervention type: DIAGNOSTIC_TEST
Intervention: physiology
Description: physiologic (autonomic) measurements will be performed during the oral comprehension testing

Intervention type: DIAGNOSTIC_TEST
Intervention: imaging
Description: central (brain) measurements will be performed during the oral comprehension testing

Intervention type: DIAGNOSTIC_TEST
Intervention: imaging
Description: central (brain) measurements will be performed during the oral comprehension testing
Study: NCT05468697

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belzutifan
Description: 40 mg tablet administered orally at a dose of 120 mg.
Study: NCT04755088

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Surufatinib
Description: Subjects to receive Surufatinib 300mg on Day 1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Surufatinib
Description: Subjects to receive Surufatinib 300mg on Day 1
Study: NCT04861688

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Chinese Medicine (NeuroAiD II™ (MLC901)
Description: NeuroAiD II™ (MLC901) contains the extracts of 9 botanical active ingredients blended with commonly used excipients. The 9 botanical active ingredients are traditional herbs well documented in the Pharmacopoeia of the People's Republic of China.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo with same appearance as active intervention
Study: NCT04612712

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donafenib Tosilate Tablets
Description: In the dose exploration phase (phase I) : three doses of Donafenib tosylate tablets \[50 mg twice a day; 100 mg twice a day; 200 mg twice a day \] will be explored. In the dose expansion phase (phase II), patients with advanced hepatocellular carcinoma will be treated at the recommended dose for phase 2(RP2D).The RP2D will be determined by the dose escalation study.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KN046 Injection
Description: 5mg/kg Q3W
Study: NCT05468697

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belzutifan
Description: 40 mg tablet administered orally at a dose of 120 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belzutifan
Description: 40 mg tablet administered orally at a dose of 120 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belzutifan
Description: 40 mg tablet administered orally at a dose of 120 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belzutifan
Description: 40 mg tablet administered orally at a dose of 120 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: 75, 100, or 125 mg tablet administered orally according to randomized dose for 21 days consecutive days followed by 7 days off.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: 75, 100, or 125 mg tablet administered orally according to randomized dose for 21 days consecutive days followed by 7 days off.